Israel’s Medasense (see here) assesses levels of pain in non-communicative patients using its PMD200 pain monitoring device. The technology is now being advanced on ventilated COVID-19 patients. Medtronic is distributing the tech in Europe and FDA approval is in progress.
https://nocamels.com/2020/09/israeli-pain-monitoring-firm-medasense-raises-18m/